+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Animal Vaccine Market - Global Forecast 2026-2032- Product Image
Companion Animal Vaccine Market - Global Forecast 2026-2032- Product Image
New

Companion Animal Vaccine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674687
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The companion animal vaccine market is transforming as new technologies, evolving pet owner preferences, and regulatory shifts converge, requiring manufacturers and supply chain leaders to adapt strategies for sustained growth and market resilience.

Market Snapshot

The Companion Animal Vaccine Market grew from USD 5.39 billion in 2025 to USD 5.85 billion in 2026 and is projected to reach USD 9.54 billion by 2032 at a CAGR of 8.48%. This robust expansion is shaped by more diverse pet ownership, growing wellness priorities, and increased demand for innovative vaccination platforms that address both preventive and emergent needs across mature and emerging economies.

Scope & Segmentation

  • Animal Types: Distinct market segments are determined by cats and dogs, each with unique disease risk profiles, caregiving patterns, and clinical protocols.
  • Vaccine Technologies: Inactivated, live attenuated, mRNA, recombinant, subunit, and toxoid vaccines are featured, with nuanced differentiation—such as split cell versus whole cell formulations—impacting efficacy and manufacturing.
  • Administration Routes: Mucosal (nasal and oral) and parenteral (intramuscular and subcutaneous) delivery methods influence clinical workflow, owner preference, and immune outcomes.
  • Distribution Pathways: The market covers online (e-pharmacy, manufacturer websites), bricks-and-mortar pharmacies, veterinary clinics, and animal hospitals, with each channel presenting distinct considerations for product positioning and cold chain management.
  • Geographical Focus: Coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, with attention to regional regulatory regimes, infrastructure, and public health dynamics.

Key Takeaways

  • Strategic focus has shifted to vaccine attributes such as improved safety, extended immunity duration, and dosing convenience, reflecting increased emphasis on wellness and preventive care among pet owners.
  • Manufacturers are investing in platform-based technologies for enhanced product flexibility and to support rapid adaptation to emerging pathogens.
  • Supply chain robustness has become a priority, with redundancy, nearshoring, and cold chain visibility addressing vulnerabilities exposed by recent global disruptions.
  • Digital transformation in veterinary practice—such as telemedicine and digital record-keeping—is influencing how vaccines are prescribed, tracked, and delivered, supporting omnichannel strategies.
  • Coordinated regulatory engagement, especially around One Health principles, is vital for accelerating product approvals and demonstrating transparent safety monitoring.
  • Lifecycle management and real-world evidence collection are now central to commercial and premium positioning, as companies pivot toward sustained product differentiation.

Tariff Impact

Recent United States tariff measures have compelled manufacturers to reassess sourcing, redirect procurement to alternative suppliers, and negotiate longer-term agreements. This has resulted in strategic diversification and local investment, especially for technologies and ingredients heavily reliant on global supply chains. Distribution strategies have evolved, with some organizations strengthening direct relationships with veterinary providers while others expand digital channels to preserve market reach and margin in the face of increased input costs. Heightened regulatory and customs planning supports compliance and product stability throughout transit.

Methodology & Data Sources

This report is informed by a systematic review of peer-reviewed literature, regulatory guidance, and industry analyses, combined with structured interviews across the animal health value chain. Triangulation and scenario analyses validate segment insights and stress-test strategy recommendations for the companion animal vaccine market.

Why This Report Matters

  • Delivers actionable market intelligence for aligning R&D pipelines and product platforms to clear clinical needs and evolving demand signals.
  • Supports decision-makers in navigating regulatory, supply chain, and distribution complexity for more resilient commercialization strategies.
  • Enables senior leaders to benchmark against best practices in digital adoption, omnichannel distribution, and manufacturer-clinic collaboration to maximize product adoption and protect value streams.

Conclusion

The companion animal vaccine market is at a strategic turning point where scientific innovation, operational resilience, and targeted commercialization are vital for future growth. Success will favor those who integrate agile research, robust supply strategies, and adaptive engagement with both clinicians and pet owners to unlock sustainable value in this evolving space.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Companion Animal Vaccine Market, by Animal Type
8.1. Cats
8.2. Dogs
9. Companion Animal Vaccine Market, by Vaccine Type
9.1. Inactivated
9.1.1. Split Cell
9.1.2. Whole Cell
9.2. Live Attenuated
9.3. mRNA
9.4. Recombinant
9.5. Subunit
9.6. Toxoid
10. Companion Animal Vaccine Market, by Route Of Administration
10.1. Mucosal
10.1.1. Nasal
10.1.2. Oral
10.2. Parenteral
10.2.1. Intramuscular
10.2.2. Subcutaneous
11. Companion Animal Vaccine Market, by Distribution Channel
11.1. Online
11.1.1. E Pharmacies
11.1.2. Manufacturer Websites
11.2. Pharmacies
11.3. Veterinary Clinics
11.4. Veterinary Hospitals
12. Companion Animal Vaccine Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Companion Animal Vaccine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Companion Animal Vaccine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Companion Animal Vaccine Market
16. China Companion Animal Vaccine Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Arko Corp.
17.6. Bimeda Biologicals Inc
17.7. Biogénesis Bagó S.A.
17.8. Boehringer Ingelheim International GmbH
17.9. Ceva Santé Animale
17.10. Dechra Pharmaceuticals PLC
17.11. Elanco Animal Health Incorporated
17.12. Endovac Animal Health
17.13. Hester Biosciences Limited
17.14. Hipra S.A.
17.15. Huvepharma, Inc.
17.16. Indian Immunologicals Ltd.
17.17. Kemin Industries, Inc.
17.18. Merck & Co., Inc.
17.19. Neogen Corporation
17.20. Pfizer, Inc.
17.21. Phibro Animal Health Corporation
17.22. SAN Group Biotech Germany GmbH
17.23. Seppic by Air Liquide Healthcare
17.24. SK Bioscience
17.25. Vaxxinova
17.26. Virbac S.A.
17.27. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 117. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 119. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 120. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 131. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 135. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 137. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 138. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 152. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 154. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 156. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 157. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. ASEAN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 159. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 161. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 162. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 163. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 165. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 166. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. GCC COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 177. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 179. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 181. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 183. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 184. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. BRICS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 186. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 188. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 189. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 190. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 191. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 192. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 193. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. G7 COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 195. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 197. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 198. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 199. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 201. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 202. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. NATO COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 214. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 216. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 217. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2032 (USD MILLION)
TABLE 218. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 219. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2032 (USD MILLION)
TABLE 220. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2032 (USD MILLION)
TABLE 221. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. CHINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Companion Animal Vaccine market report include:
  • Arko Corp.
  • Bimeda Biologicals Inc
  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Limited
  • Hipra S.A.
  • Huvepharma, Inc.
  • Indian Immunologicals Ltd.
  • Kemin Industries, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Pfizer, Inc.
  • Phibro Animal Health Corporation
  • SAN Group Biotech Germany GmbH
  • Seppic by Air Liquide Healthcare
  • SK Bioscience
  • Vaxxinova
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.85 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.54 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Animal Vaccines Market - Global Forecast 2026-2032 - Product Image

Animal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Veterinary Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Companion Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Companion Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Companion Animal Vaccine Market Report and Forecast 2025-2034 - Product Image

Companion Animal Vaccine Market Report and Forecast 2025-2034

  • Report
  • 178 Pages
  • Global
From
Companion Animal Vaccines - Global Strategic Business Report - Product Image

Companion Animal Vaccines - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From

About the Companion Animal Vaccine Market

Within the realm of animal healthcare and veterinary medicine, the Companion Animal Vaccine market is an essential segment focused on the immunization of pets, such as dogs, cats, and horses, against various infectious diseases. This sector addresses the preventative healthcare needs of companion animals by providing a variety of vaccines that target illnesses such as rabies, distemper, parvovirus, and feline leukemia, among others. The availability and development of these vaccines are driven by continuous scientific research, technological advancements, and an increasing awareness among pet owners about the importance of preventative care. Moreover, this market is influenced by regulatory frameworks and animal welfare organizations advocating for the health and safety of companion animals. The administration of vaccines is a critical component of routine veterinary care, aiming to ensure the longevity and quality of life of pets, whilst also aiding in the control of disease outbreaks that could potentially affect human populations as well. Prominent players in the companion animal vaccine market include Zoetis, Merck Animal Health (known as MSD Animal Health outside the United States and Canada), Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, and Ceva Santé Animale. These companies are noteworthy for their extensive research and development efforts, comprehensive vaccine portfolios, and substantial contributions to veterinary medicine and overall animal health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.